Normally, insulin supports lymphangiogenesis and LEC proliferation via PI3K/AKT and extracellular signal-regulated kinase (ERK) pathways.30,31 However, in insulin resistance, dysregulated insulin signaling impairs these processes, reducing lymphangiogenesis, lymphatic drainage, and increasing inflammation in lymphatic vessels. Here, INS is linked to Insulin resistance.